FMR LLC 13D/13G Filings for Krystal Biotech, Inc. (KRYS)

FMR LLC 13D and 13G filings for Krystal Biotech, Inc.:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Shares have been adjusted for stock splits.
Time period
Reported
DateTime
Transaction
Date
TypeCompany
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev ReportView
2024-11-12
10:32 am
Purchase
2024-11-0813GKrystal Biotech, Inc.
KRYS
FMR LLC4,292,881
14.942%
943,407increase
(+28.17%)
Filing
2024-02-12
12:03 pm
Purchase
2024-02-0913GKrystal Biotech, Inc.
KRYS
FMR LLC3,349,474
11.874%
963,576increase
(+40.39%)
Filing
2024-02-09
09:16 am
Sale
2024-02-0813GKrystal Biotech, Inc.
KRYS
FMR LLC2,385,898
8.458%
-227,374decrease
(-8.70%)
Filing
2023-05-10
09:45 am
Purchase
2023-05-0913GKrystal Biotech, Inc.
KRYS
FMR LLC2,613,272
10.133%
504,419increase
(+23.92%)
Filing
2023-02-09
11:18 am
Purchase
2023-02-0913GKrystal Biotech, Inc.
KRYS
FMR LLC2,108,853
8.190%
130,564increase
(+6.60%)
Filing
2022-02-09
09:22 am
Purchase
2022-02-0813GKrystal Biotech, Inc.
KRYS
FMR LLC1,978,289
7.879%
725,903increase
(+57.96%)
Filing
2021-02-08
10:27 am
Purchase
2021-02-0513GKrystal Biotech, Inc.
KRYS
FMR LLC1,252,386
6.354%
104,100increase
(+9.07%)
Filing